Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes

Company Overview - Senseonics Holdings, Inc. is a medical technology company focused on developing and manufacturing long-term implantable continuous glucose monitoring (CGM) systems for diabetes management [5] Upcoming Event - The company will host an in-person and virtual analyst event on June 21, 2025, at 8:00 am CT during the American Diabetes Association 85th Scientific Sessions [1] - The event will feature discussions on the next-generation Eversense® 365 CGM system, which has been approved by the FDA for individuals aged 18 and older [2] Event Details - Company management will present alongside Brian Hansen from Ascencia Diabetes Care, who will discuss the commercial launch of Eversense 365, and Gary Graf from Cotton-O'Neil Diabetes and Endocrinology Center, who will share insights on the Eversense system and its insertion procedure [3] - The event will also cover a recently announced partnership with Sequel to integrate with the twiist automated insulin delivery pump and plans to advance the pipeline of implantable CGM technology [3] - A live question and answer session will follow the formal presentations [4]